UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Small cell carcinoma of the urinary bladder: The Mayo Clinic experience

Cancer, 2005-03, Vol.103 (6), p.1172-1178

2005

Volltextzugriff (PDF)

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

Clinical cancer research, 2019-05, Vol.25 (10), p.2988-2995

2019

Volltextzugriff (PDF)

EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation

The Journal of biological chemistry, 2010-06, Vol.285 (24), p.18575-18585

2010

Volltextzugriff (PDF)

Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia

The New England journal of medicine, 2011-02, Vol.364 (7), p.688-689

2011

Volltextzugriff (PDF)

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

Investigational new drugs, 2010-10, Vol.28 (5), p.677-683

2010

Volltextzugriff (PDF)

Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy

Journal of thoracic oncology, 2009-05, Vol.4 (5), p.661-662

2009

Volltextzugriff (PDF)

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-09, Vol.3 (9), p.1003-1011

2008

Volltextzugriff (PDF)

Recurrent Laryngeal Nerve Palsy on Integrated Positron Emission Tomography-Computed Tomography

Journal of thoracic oncology, 2008-10, Vol.3 (10), p.1172-1172

2008

Volltextzugriff (PDF)

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

The New England journal of medicine, 2014-11, Vol.371 (20), p.1867-1876

2014

Volltextzugriff (PDF)

Stereotactic Radiosurgery for the Management of Brain Metastases

The New England journal of medicine, 2010-08, Vol.363 (6), p.591-593

2010

Volltextzugriff (PDF)

Therapeutic targeting of receptor tyrosine kinases in lung cancer

Expert opinion on therapeutic targets, 2005-06, Vol.9 (3), p.533-559

2005

Volltextzugriff (PDF)

Key Signaling Pathways and Targets in Lung Cancer Therapy

Clinical lung cancer, 2007-02, Vol.8, p.S52-S60

2007

Volltextzugriff (PDF)

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy

Journal of thoracic oncology, 2009-12, Vol.4 (12), p.1590-1591

2009

Volltextzugriff (PDF)

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-01, Vol.3 (1), p.59-67

2008

Volltextzugriff (PDF)

Diagnosis to Treatment Interval and Outcome in Patients with Locally-Advanced Squamous Cell Carcinoma of the Head and Neck in a Veterans Affairs Medical Center

Journal of cancer science & therapy, 2012, Vol.4 (5)

2012

Volltextzugriff (PDF)

Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer

Journal of thoracic oncology, 2006-03, Vol.1 (3), p.245-251

2006

Volltextzugriff (PDF)

Forthcoming receptor tyrosine kinase inhibitors

Expert opinion on therapeutic targets, 2006-12, Vol.10 (6), p.793-797

2006

Volltextzugriff (PDF)

Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer

Clinical lung cancer, 2005-12, Vol.7 Suppl 3, p.S98-S104

2005

Volltextzugriff (PDF)

A randomized phase II study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: S1613

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS3620-TPS3620

2018

Volltextzugriff (PDF)

Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics

Clinical pharmacology in drug development, 2021-02, Vol.10 (2), p.144-152

2021

Volltextzugriff (PDF)

Extended follow-up results of phase Ib study (BRIM7) of vemurafenib (VEM) with cobimetinib (COBI) in BRAF -mutant melanoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.9020-9020

2015

Volltextzugriff (PDF)

Extended follow-up results of a phase 1B study (BRIM7) of cobimetinib (C) and vemurafenib (V) in BRAF -mutant melanoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9510-9510

2016

Volltextzugriff (PDF)

E3508: Randomized trial of carboplatin (C), paclitaxel (P), bevacizumab (B) with or without cixutumumab (Cx) in patients (pts) with advanced non-squamous, non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9091-9091

2016

Volltextzugriff (PDF)

Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2573-2573

2015

Volltextzugriff (PDF)

Clinical features of cobimetinib (COBI)–associated serous retinopathy (SR) in BRAF -mutated melanoma patients (pts) treated in the coBRIM study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.9033-9033

2015

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Humans
(36)
Female
(19)
Male
(18)
Adult
(13)
Aged
(12)
Middle Aged
(10)
Oncology
(10)
Respiratory System
(8)
Pediatrics
(7)
General & Internal Medicine
(6)
Knee
(6)
Lung Neoplasms - Drug Therapy
(6)
Radiation Therapy
(6)
Rehabilitation
(6)
Aged, 80 And Over
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Combined Modality Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Small cell carcinoma of the urinary bladder: The Mayo Clinic experience

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation

Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Recurrent Laryngeal Nerve Palsy on Integrated Positron Emission Tomography-Computed Tomography

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

Stereotactic Radiosurgery for the Management of Brain Metastases

Therapeutic targeting of receptor tyrosine kinases in lung cancer

Key Signaling Pathways and Targets in Lung Cancer Therapy

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

Diagnosis to Treatment Interval and Outcome in Patients with Locally-Advanced Squamous Cell Carcinoma of the Head and Neck in a Veterans Affairs Medical Center

Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer

Forthcoming receptor tyrosine kinase inhibitors

Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer

A randomized phase II study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: S1613

Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics

Extended follow-up results of phase Ib study (BRIM7) of vemurafenib (VEM) with cobimetinib (COBI) in BRAF -mutant melanoma

Extended follow-up results of a phase 1B study (BRIM7) of cobimetinib (C) and vemurafenib (V) in BRAF -mutant melanoma

E3508: Randomized trial of carboplatin (C), paclitaxel (P), bevacizumab (B) with or without cixutumumab (Cx) in patients (pts) with advanced non-squamous, non-small cell lung cancer (NSCLC)

Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors

Clinical features of cobimetinib (COBI)–associated serous retinopathy (SR) in BRAF -mutated melanoma patients (pts) treated in the coBRIM study

Aktive Filter

Suchergebnisse filtern